Colorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland.
With communities across the nation experiencing a wave of COVID-19 infections, clinicians need effective tools that will enable them to aggressively and accurately treat each patient based on their specific disease presentation, health history, and medical risks.
In research recently published online in Medical Image Analysis, a team of engineers demonstrated how a new algorithm they developed was able to successfully predict whether or not a COVID-19 patient would need ICU intervention. This artificial intelligence-based approach could be a valuable tool in determining a proper course of treatment for individual patients.
The research team, led by Pingkun Yan, an assistant professor of biomedical engineering at Rensselaer Polytechnic Institute, developed this method by combining chest computed tomography (CT) images that assess the severity of a patient’s lung infection with non-imaging data, such as demographic information, vital signs, and laboratory blood test results. By combining these data points, the algorithm is able to predict patient outcomes, specifically whether or not a patient will need ICU intervention.
The algorithm was tested on datasets collected from a total of 295 patients from three different hospitals — one in the United States, one in Iran, and one in Italy. Researchers were able to compare the algorithm’s predictions to what kind of treatment a patient actually ended up needing.
“As a practitioner of AI, I do believe in its power,” said Yan, who is a member of the Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer. “It really enables us to analyze a large quantity of data and also extract the features that may not be that obvious to the human eye.”
This development is the result of research supported by a recent National Institutes of Health grant, which was awarded to provide solutions during this worldwide pandemic. As the team continues its work, Yan said, researchers will integrate their new algorithm with another that Yan had previously developed to assess a patient’s risk of cardiovascular disease using chest CT scans.
“We know that a key factor in COVID mortality is whether a patient has underlying conditions and heart disease is a significant comorbidity,” Yan said. “How much this contributes to their disease progress is, right now, fairly subjective. So, we have to have a quantification of their heart condition and then determine how we factor that into this prediction.”
“This critical work, led by Professor Yan, offers an actionable solution for clinicians who are in the middle of a worldwide pandemic,” said Deepak Vashishth, the director of CBIS. “This project highlights the capabilities of Rensselaer expertise in bioimaging combined with important partnerships with medical institutions.”
Yan is joined at Rensselaer by Ge Wang, an endowed chair professor of biomedical engineering and member of CBIS, as well as graduate students Hanqing Chao, Xi Fang, and Jiajin Zhang. The Rensselaer team is working in collaboration with Massachusetts General Hospital. When this work is complete, Yan said, the team hopes to translate its algorithm into a method that doctors at Massachusetts General can use to assess their patients.
“We actually are seeing that the impact could go well beyond COVID diseases. For example, patients with other lung diseases,” Yan said. “Assessing their heart disease condition, together with their lung condition, could better predict their mortality risk so that we can help them to manage their condition.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Covid-19 outcomes
- COVID-19 Worsened overuse of antibiotics, WHO raises concern over dangers of Antimicrobial Resistance
The use of antibiotics was highly seen among patients with severe or critical COVID-19, with a global average of 81%.
- 'Just in case' antibiotics widely overused during COVID-19, says UN health agency
Antibiotics saw 'extensive overuse' globally among hospitalised COVID-19 patients during the pandemic without improving clinical outcomes, while also potentially increasing the already serious and ...
- Psychiatric Disorders Do Not Decrease COVID-19 Vaccine Effectiveness
Researchers conducted a retrospective cohort analysis to evaluate the effectiveness of COVID-19 vaccination among US adults with common psychiatric disorders.
- Event Report: Symposium on the impact of the COVID-19 pandemic on cancer outcomes
Watch seven eLife authors showcase their research from our recent Special Issue.
- Study: Antibiotic use in patients hospitalized with COVID-19 appears to have no beneficial effect on clinical outcomes
Antibiotic treatment of adults hospitalized with moderate COVID-19 is associated with clinical deterioration, despite the drugs being given to over 40% of patients, according to new research being ...
Go deeper with Google Headlines on:
Covid-19 outcomes
[google_news title=”” keyword=”Covid-19 outcomes” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Artificial intelligence algorithm
- Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves
Nvidia's second-largest holding is a 3.4% stake in Recursion Pharmaceuticals ( RXRX 3.57%). The company is using AI to mine data and discover new potential drugs. And if it successfully develops a ...
- 3 Under-the-Radar Artificial Intelligence (AI) Stocks to Buy Now
Cybersecurity is a remarkably competitive but crowded market. Eventually, the cream rises to the top, and SentinelOne is among the best security products. It's a regular high-performer on third-party ...
- U.S. Government Needs to ‘Get It Right’ on Artificial Intelligence
We can't afford to get this wrong—again,” Shalanda Young, the director of the Office of Management and Budget, tells TIME.
- Colorado lawmakers consider landmark artificial intelligence regulations
Colorado could be one of the first states to broadly regulate generative artificial intelligence, as lawmakers consider the balance between setting guardrails on a potentially-harmful technology and ...
- The Power of Algorithms: 10 Ways Generative AI is Revolutionizing the Way We Shop Online
In the dynamic world of online shopping, algorithms are reshaping the way we browse, choose, and purchase products. Generative AI is at the forefront of this revolution, harnessing cutting-edge ...
Go deeper with Google Headlines on:
Artificial intelligence algorithm
[google_news title=”” keyword=”artificial intelligence algorithm” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]